News about Drug Discovery & Development

BIOTRONIK Launches Micro Rx Catheter for Enhanced Guidewire Support in Coronary Interventions

BIOTRONIK Launches Micro Rx Catheter for Enhanced Guidewire Support in Coronary Interventions

Developed exclusively by BIOTRONIK and manufactured by IMDS, this innovative device marks a significant addition to the company's robust portfolio of interventional solutions in the US.

Drug Discovery & Development | 12/02/2024 | By Manvi 574

Boehringer Ingelheim and CBmed Forge Partnership to Advance Cancer Treatment Development

Boehringer Ingelheim and CBmed Forge Partnership to Advance Cancer Treatment Development

The partnership, unveiled with great anticipation, will harness translational medicine approaches to drive the advancement of first-in-class therapies, ultimately aiming to revolutionize the lives of individuals battling cancer.

Drug Discovery & Development | 12/02/2024 | By Manvi 455

Domrex Pharma Expands Its Reach with Launch of Domrex Pharma USA

Domrex Pharma Expands Its Reach with Launch of Domrex Pharma USA

Originating in Quebec, Domrex Pharma has successfully positioned itself as a key player in the healthcare industry, catering to hospitals, pharmacies, clinics, and long-term care facilities across Canada.

Drug Discovery & Development | 02/02/2024 | By Manvi 670

Pfizer and Glenmark Partners to Bring Treatment for Atopic Dermatitis to India

Pfizer and Glenmark Partners to Bring Treatment for Atopic Dermatitis to India

Abrocitinib, set to be launched in India under the brand names JABRYUS® and CIBINQO® by Glenmark and Pfizer, respectively, marks a breakthrough in the treatment of AD.

Drug Discovery & Development | 01/02/2024 | By Manvi 655

Turkish Cargo Elevates Pharmaceutical Logistics with Launch of TK Pharma Product Line

Turkish Cargo Elevates Pharmaceutical Logistics with Launch of TK Pharma Product Line

The introduction of its innovative products—TK Pharma Standard, TK Pharma Extra, and TK Pharma Advanced—aims to meet customer expectations by offering flexible solutions for pharmaceutical and medical consignments.

Drug Discovery & Development | 31/01/2024 | By Manvi 693

LifeSprout Signs Agreement with Boyang Trading to Develop and Commercialize Next-Generation Lumina Dermal Filler

LifeSprout Signs Agreement with Boyang Trading to Develop and Commercialize Next-Generation Lumina Dermal Filler

Lumina is the first product from LifeSprout's proprietary Regenerative Matrix platform. The technology comprises biomimetic, biocompatible, biodegradable materials engineered to look and feel like native soft tissue.

Drug Discovery & Development | 31/01/2024 | By Manvi 580

Uppaluri K&H Personalized Medicine Clinic Unveil AI platform - GeneConnectRx

Uppaluri K&H Personalized Medicine Clinic Unveil AI platform - GeneConnectRx

Uppaluri K&H Personalized Medicine Clinic Pvt Ltd., unveiled GeneConnectRx, an innovative AI platform from GenepoweRx, the diagnostic wing of the group.

Drug Discovery & Development | 09/01/2024 | By Manvi 689

Union Health Minister Inaugurates CDSCO Sub Zonal Office and Central Drug Testing Laboratory in MP

Union Health Minister Inaugurates CDSCO Sub Zonal Office and Central Drug Testing Laboratory in MP

Dr. Mansukh Mandaviya, Union Minister of Health and Family Welfare inaugurated the Central Drugs Standard Control Organization (CDSCO) Sub Zonal office and Central Drug Testing Laboratory (CDTL) in Indore, Madhya Pradesh.

Drug Discovery & Development | 08/01/2024 | By Manvi 1013

BridGene Biosciences Establishes Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets

BridGene Biosciences Establishes Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets

Under the collaboration, BridGene will use its chemoproteomics platform, IMTAC™, to discover novel small molecule drug candidates against the collaboration targets.

Drug Discovery & Development | 05/01/2024 | By Manvi 581

Boehringer Ingelheim Inks Second Pact with 3T Biosciences to Develop Cancer Immunotherapies

Boehringer Ingelheim Inks Second Pact with 3T Biosciences to Develop Cancer Immunotherapies

This second research partnership with 3T builds on the successful completion of the initial research partnership announced last year by the two companies.

Drug Discovery & Development | 05/01/2024 | By Manvi 612

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members